Osteopontin expression by osteoclast and osteoblast progenitors in the murine bone marrow: Demonstration of its requirement for osteoclastogenesis and its increase after ovariectomy

Endocrinology

Volumn 138, Issue 7, 1997, Pages 3047-3055

  Yamate, Tomoo ^a,b   Mocharla, Hanna ^b   Taguchi, Yasuto ^a   Igietseme, Joseph U ^b   Manolagas, Stavros C ^a   Abe, Etsuko ^a  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; MESSENGER RNA; OSTEOPONTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; CELL CONTACT; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; MALE; MOUSE; NONHUMAN; OSTEOBLAST; OVARIECTOMY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT;

EID: 0030924823     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.7.5285     Document Type: Article

References (39)

1. Ishimi Y, Miyaura C, Jin CH, Akatsu T, Abe E, Nakamura N, Yamaguchi A, Yoshiki S, Malsuda T, Hirano T, Kishimolo T, Suda T1990IL-6 is produced by osteoblasts and induces bone résorption. J Immunol 145:3297-3303
2. Manolagas SC, Jilka RL1995 Bone marrow, cytokines and bone remodeling. N Engl J Med 332:305-311
3. Greenfield EM, Gornik SA, Horowitz MC, Donahue HJ, Shaw SM 1993 Regulation of cytokine expression in osteoblasts by parathyroid hormone: rapid stimulation of interleukin-6 and leukemia inhibitory factor mRNA. J Bone Miner Res 8:1163-1171
4. Girasole G, Passeri G, Jilka RL, Manolagas SC 1994 Interleukin 11: a new cytokine critical for osteoclast development. J Clin Invest 93:1516-1524
5. Takahashi N, Udagawa N, Akatsu T, Tanaka S, Isogai Y, Suda T 1991 Deficiency of osteoclasts in osteopetrotic mice is due to a defect in the local environment provided by osteoblastic cells. Endocrinology 128:1792-1796
6. Hong MH, Jin CH, Sato T, Ishimi Y, Abe E, Suda T 1991 Transcriptional regulation of the production of the third component of complement (C3) by lot, 25-dihydroxyvitamin D3 in bone marrow derived stromal cells (ST2) and primary osteoblastic cells. Endocrinology 129:2774-2779
7. Jin CH, Shinki T, Hong MH, Sato T, Yamaguchi A, Ikeda T, Yoshiki S, Abe E, Suda T1992 la, 25-Dihydroxyvitamin D3 regulates in vivo production of the third component of complement (C3) in bone. Endocrinology 131:2468-2475
8. Takahashi N, Akatsu T, Udagawa N, Sasaki T, Yamaguchi A, Moseley JM, Martin TJ, Suda T1988 Osteoblastic cells are involved in osteoclast formation. Endocrinology 123:2600-2602
9. Suda T, Takahashi N, Martin TJ 1992 Modulation of osteoclast differentiation. Endocr Rev 13:66-80
10. Suda T, Udagawa N, Takahashi N 1995 Modulation of osteoclast differentiation: update. Endocr Rev 4:266-270
11. Denhardt DT, Guo X 1993 Osteopontin: a protein with diverse functions. FASEB J 7:1475-1483
12. Rodan GA1995 Osteopontin overview. Osteopontin: role in cell signaling and adherence. Ann NY Acad Sei 760:1-6
13. Bautista DS, Xuan J-W, Hota C, Chambers AF, Harris JF 1994 Inhibition of Arg-Gly-Asp (RGD)-mediated cell adhesion to Osteopontin by a monoclonal antibody against Osteopontin. J Biol Chem 269:23280-23285
14. Aarden EM, Nijweide PJ, Van Der Plas A, Alblas MJ, Mackie EJ, Horion MA, Helfrich MH 1996 Adhesive properties of isolated chick osteocytes in vitro. Bone 18:305-313
15. Oldberg A, Franzan A, Heinegard D 19S6 Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sei USA 83:8819-8823
16. Yoon K, Buenaga R, Rodan GA 1987 Tissue specificity and developmental expression of rat osteopontin. Biochem Biophys Res Commun 13:1129-1136
17. Nomura S, Wills AJ, Edwards DR, Heath JK, Hogan BLM 1988 Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by HI si'fu hybridization. J Cell Biol 106:441-450
18. Chen J, Singh K Mukherjee BB, Sodek J 1993 Developmental expression of osteopontin (OPN) mRNA in rat tissues; evidence for a role for OPN in bone formation and résorption. Matrix 13:113-123
19. Mckee MD, Farach-Carson MC, Buller WT, Hauschka PW, Nanci A 1993 Ultrastructural immunolocalization of non-collagenous (osteopontin and osteocalcin) and plasma (albumin and a 2HS-glycoprotein) proteins in rat bone. J Bone Miner Res 8:485-496
20. Ikeda T, Nomura S, Yamaguchi A, Suda T, Yashiki S 1992 In situ hybridization of bone matrix protein in undecalcified adult rat bone section. J Histochem Cytochem 46:1079-1088
21. Merry K, Dodds R, Littlewood A, Gowen M 1993 Expression of osteopontin mRNA by osteoclasts and osteoblasts in modeling adult human bone. J Cell Sei 104:1013-1020
22. Dodds RA, Connor JR, James IA, Rykaczewski EL, Appelbaum E, Dul E, Gowen M 1995 Human osteoclasts, not osteoblasts, deposit osteopontin onto résorption surface: an in vitro and ex vivo study of remodeling bone. J Bone Miner Res 10:1666-1680
23. Jilka RL, Hangoc G, Girasole G, Passen DC, Williams JS, Abrams B, Boyce H, Broxmyer H, Manolagas SC 1992 Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257:88-91
24. Flore ME, Norgard M, Heinegard D, Reinholt FF, Andersson G 1992 RGDdirected attachment of isolated rat osteoclasts to osteopontin, bone sialoprotein, and fibronectin. Exp Cell Res 201:526-530
25. Nakamura I, Takahashi N, Sasaki T, Jimi E, Kurokawa T, Suda T 1996 Chemical and physical properties of the extracellular matrix are required for the actin ring formation in osteoclasts. J Bone Miner Res 11:1873-1879
26. Takahashi N, Udagawa N, Tanaka S, Murakami H, Owan I, Tamura T, Suda T1994 Postmitotic osteoclast precursors are mononuclear cells which express macrophage-associated phenotypes. Dev Biol 163:212-221
27. Noda M, Vogel RL, Craig A M, Prahl J, Deluca H F, Denhardt DT 1990 Identification of a DNA sequence responsible for binding of the 1,25-dihydroxyvitamin D3 receptor and 1,25-dihydroxyvitamin D3 enhancement of mouse secreted phosphoprotein 1 (Spp-1 or osteopontin) gene expression. Proc Natl Acad Sei USA 87:9995-9999
28. Jin CH, Miyaura C, Ishimi Y, Hong HM, Sato T, Abe E, Suda T 1990 Interleukin 1 regulates the expression of osteopontin mRNA by osteoblasts. Mol Cell Endocrinol 74:221-228
29. Takahashi K, Jilka RL, Manolagas SC 1996 Estrogens alters the responsiveness of osteoblast progenitors to leukemia inhibitory factor (L1F). J Bone Miner Res 11:5129
30. Ikeda T, Yamaguchi A, Yokose S, Nagai Y, Yamato H, Nakamura T, Tsurukami H, Tanizawa T, Yoshiki S 1996 Changes in biological activity of bone cells in ovariectomized rats revealed by in situ hybridization. J Bone Miner Res 11:780-788
31. Yamate T, Mocharla H, Taguchi Y, Abe E, Manolagas SC 1996 Démonstration, by in situ RT-PCR, of increased expression of both the IL-6 and the IL-6 receptor a mRNA in the bone marrow following estrogen loss. J Bone Miner Res 11:5105
32. Horton MA, Taylor ML, Arnctt TR, Helfrich MH 1991 Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit cell spreading and dentin résorption by osteoclasts. Exp Cell Res 195:368-375
33. Ross FF, Chappel J, Arvarez JI, Sander D, Butler WT, Farach-Carsen MC, Minz KA, Robey PG, Teitelbaum SL, Cheresh DA 1993 Interaction between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin av/33 potentiate bone résorption. J Biol Chem 268:9901-9907
34. Hruska K, Rolnick F, Huskey M, Alvarez U, Cheresh D 1995 Engagement of the osteoclast integrin av/33 by osteopontin stimulates phosphatidylinosytol 3-hydroxy kinase activity. Endocrinology 136:2984-2992
35. Felix R, Halasy-Nagy J, Wetterwald A, Cecchini MG, Fleish H, Hofstetter W 1996 Synthesis of membrane- and matrix-bound colony-stimulating factor-1 by cultured osteoblasts. J Cell Physiol 166:311-322
36. Gough NM, Metcalf D, Cough J, Grail D, Dünn AR 1985 Structure and expression of the mRNA for murine granulocyte-macrophage colony-stimulating factor. EMBO J 4:645-653
37. Weber GF, Ashkar S, Glimcher MJ, Cantor H 1996 Receptor-ligand interaction between CD44 and osteopontin (eta-1). Science 271:509-512
38. Nakamura H, Kenmotsu S, Sakai H, Ozawa H1995 Localization of CD44, the hyaluronate receptor, on the plasma membrane of osteocytes and osteoclasts in rat tibiae. Cell Tissue Res 280:225-233
39. Udagawa N, Findlay DM, Martin TJ 1996 CD44 involvement in osteoclast differentiation as well as bone résorption by mature osteoclasts. J Bone Miner Res 115112